Fausto Chiazza
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research 11
-
- Diet, Metabolism, and Disease 10
- Nephrology top 5%
- Physiology top 10%
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 8
- Sepsis Diagnosis and Treatment 5
-
- Immune Response and Inflammation 7
-
- Inflammasome and immune disorders 6
-
- Cardiac Ischemia and Reperfusion 6
-
- Eicosanoids and Hypertension Pharmacology 4
- Co-authors
- Massimo CollinoRaffaella MastrocolaManuela AragnoDebora NigroElisa BenettiChristoph ThiemermannNimesh S. A. PatelDebora Collotta
- Journals
- Oxidative Medicine and Cellular Longevity (5 papers)PLoS ONE (5 papers)Scientific Reports (3 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Fausto Chiazza
55 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 106
- Clinical Biochemistry 183
- Endocrinology, Diabetes and Metabolism 352
- Nephrology 128
- Physiology 347
- Epidemiology 458
Countries citing papers authored by Fausto Chiazza
This map shows the geographic impact of Fausto Chiazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fausto Chiazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fausto Chiazza more than expected).
Fields of papers citing papers by Fausto Chiazza
This network shows the impact of papers produced by Fausto Chiazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fausto Chiazza. The network helps show where Fausto Chiazza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fausto Chiazza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 56 | |
| 9 | 2020 | 44 | |
| 10 | 2020 | 27 | |
| 11 | 2018 | 76 | |
| 12 | 2018 | 23 | |
| 13 | 2018 | 9 | |
| 14 | Role of the beta-d-endoglucuronidase heparanase in septic cardiomyopathy | 2017 | 2 |
| 15 | 2017 | 55 | |
| 16 | 2017 | 44 | |
| 17 | 2016 | 131 | |
| 18 | 2016 | 47 | |
| 19 | 2015 | 58 | |
| 20 | 2015 | 36 |
About Fausto Chiazza
Fausto Chiazza is a scholar working on Clinical Biochemistry, Developmental Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 56 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (11 papers), Diet, Metabolism, and Disease (10 papers), Liver Disease Diagnosis and Treatment (8 papers), Immune Response and Inflammation (7 papers), Inflammasome and immune disorders (6 papers), Cardiac Ischemia and Reperfusion (6 papers), Sepsis Diagnosis and Treatment (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Clinical Biochemistry (183 citations), Endocrinology, Diabetes and Metabolism (352 citations) and Nephrology (128 citations). Fausto Chiazza has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Massimo Collino, Raffaella Mastrocola, Manuela Aragno, Debora Nigro, Elisa Benetti, Christoph Thiemermann, Nimesh S. A. Patel, Debora Collotta, Roberto Fantozzi and Alessia Sofia Cento. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, PLoS ONE, Scientific Reports, Frontiers in Immunology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.